[2][3][4] It resulted in the following marketed combined injectable contraceptives:[3][4][5][6][7][8][9][10] And in the following never-marketed progestogen injectable contraceptives:[2][5] Since the first United Nations World Population Conference, held in Rome in 1954, the United Nations had a growing interest in the issue of demography and associated it with the economic difficulties of developing countries.
following a request of the UN General Assembly,[11] the Secretary-General conducted an inquiry among the member-States and concluded there were indeed concerns among the developing countries about the growth of their populations.
[15] Pleased by the progress made, the World Health Assembly requested the Director-General to consider a way to develop family planning services.
Fourth, the creation of an international documentation centre on biomedical aspects of human reproduction (this point was not executed due to limited funding at the time).
[18] He presented a report on this matter in December of the same year, including human reproduction and especially the Expanded Programme in the researches to fund.
[21] The technical details of the scientific projects, the control of the publications and works of the Task Forces were delegated to a Review Group, which also designated the Clinical Research Centres.
The PCAC became the Policy and Coordination Committee (PCC), in charge of the administration, the approval of the budget, and the general orientation of the work of the Programme and included the co-sponsors as permanent members.
A Standing Committee, composed of representatives of the co-sponsors meets thrice a year, monitors the Programme situation and formulates recommendations to the PCC.
Ultimately, following a global reform of the WHO structure in 2019, the RHR was placed under the responsibility of the UHC/Life Course Division and became the Department of Sexual and Reproductive Health and Research (SRH).